Business
How Does Cannabis Impact Women’s Fertility And Ovulation?
While there are few studies so far analyzing the effects of cannabis products and women’s ovulation, the current findings are promising.
Cannabis-consuming women in child bearing age may be concerned about the impact of their habits. Everything we put into our body can increase or decrease our chances of conceiving a baby. However, age is the most important factor that determines a woman’s fertility; all females are born with a finite number of eggs, and the quality and quantity of those eggs will both reduce with age.
Other factors also include genetics, hormones, medical history, and lifestyle. Women who are overweight or underweight, have irregular sleeping patterns, consume alcohol and smoke tobacco typically have a reduced chance of conceiving especially above the age of 35. But what about cannabis?
Marijuana is the most widely used recreational drug especially among adults of child-bearing age. Additionally, cannabidiol (CBD) products are also widely used among women of all ages especially for treating several conditions affecting the reproductive system.
Studies and Polls Indicate How Cannabis Affects Fertility
A 2018 poll of women in the United States and Canada was conducted by researchers at the Boston University School of Public Health. The results, which were shared in the Journal of Epidemiology and Community Health, was the first study to analyze any associations between conception probability and cannabis consumption.
More than 4,000 (4,194) women aged of 21 to 45 participated in the Pregnancy Study Online (PRESTO), which was focused on women who were in stable heterosexual relationships, not using any fertility treatment or contraception. The women were also given the choice to invite their male partners for the poll.
The results showed that from 2013 through 2017, some 12% of female subjects and 14% of the males admitted to using marijuana two months before answering the PRESTO survey. They engaged in 12 follow-up cycles, after which it was found that the probability for conception was similar among the heterosexual couples who consumed marijuana as well as those that didn’t.
“Given the increasing number of states legalizing recreational marijuana across the nation, we thought it was an opportune time to investigate the association between marijuana use and fertility,” explains Lauren Wise, the study’s lead author and a Boston University professor of epidemiology.
Other studies show that CBD may help women who struggle with hormonal imbalances. Several hormonal abnormalities decrease the chances of ovulation and can interrupt it, making pregnancy unlikely and even impossible.
Hormonal imbalances can be tricky to treat. Oftentimes it presents in cysts and may require the use of surgery, lifestyle changes, and medication — many times two or more treatment methods, just to be successful.
But a study has shown that consuming CBD can be beneficial in regulating secretion of cortisol, a stress hormone. High levels of cortisol in the body can affect other hormones such as sex hormone and thyroid-stimulating hormones. Because of this, any method that is effective in reducing cortisol is beneficial for supporting overall hormone balance. On top of that, CBD is rich in omega fatty acids as well as gamma linolenic acid, which help stabilize hormones.
Another study from 2017 analyzed the impact of cannabinoids on endometriosis. “Pain management for patients with endometriosis needs to be more effective, target the hormonal and immunologic environment, downregulate proliferation while enhancing apoptosis, and normalize the invasive mechanisms and neuroangiogenesis processes. ECS (endocannabinoid system) modulation appears to be a good therapeutic strategy by potentially combining all these factors,” concluded the study authors.
Excess estrogen production in a woman’s body can result in numerous fertility issues. High estrogen levels are linked to ovarian cancer, endometriosis, insulin resistance, irregular periods, and difficulty conceiving. Estrogen is produced within the varies, and other enzymes within the body also help control production and metabolize it.
Studies have found that CBD in cells is effective in inhibiting the production of estrogen by limiting an enzyme called aromatase, which produces it from testosterone. Aromatase inhibitors are utilized for decreasing estrogen production in women post menopause and those who have breast cancer.
Another study has revealed that CBD is useful in helping the body metabolize estrogen by increasing cytochrome p450 enzymes which help to break it down.
These studies point to the anti-estrogenic abilities of cannabidiol, which are helpful for women who struggle with hormone-related fertility, ovulation, and health problems.
Conclusion
The human endocannabinoid system helps to maintain balance in many important biological processes. These include fertility, stress, mood, and immunity among others. The endocannabinoid system also affects the endocannabinoid system, which is why the use of CBD and cannabis products can help provide stability for hormonal imbalances.
While there are few studies so far analyzing the effects of cannabis products and women’s ovulation, the current findings are promising. This is especially true because women often have to resort to painful and invasive treatments to manage hormonal imbalances, and problems affecting fertility and ovulation.
For women who are keen to explore the use of CBD and cannabis for treating ovulation and fertility issues, make sure to do as much research as possible on your own. It’s also advisable to speak to a fertility specialist or your gynecologist, preferably one who already has experience using cannabis or CBD products. These come in a wide range of forms and products, some of which may be more suitable than others for your specific needs.
Source: https://thefreshtoast.com/cannabis/how-does-cannabis-impact-womens-fertility-and-ovulation/
New Mexico regulators fined a cannabis operator nearly $300,000 and revoked its license after the company allegedly created fake reports in the state’s traceability software.
The New Mexico Cannabis Control Division (CCD) accused marijuana manufacturer and retailer Golden Roots of 11 violations, according to Albuquerque Business First.
Golden Roots operates the The Cannabis Revolution Dispensary.
The majority of the violations are related to the Albuquerque company’s improper use of BioTrack, which has been New Mexico’s track-and-trace vendor since 2015.
The CCD alleges Golden Roots reported marijuana production only two months after it had received its vertically integrated license, according to Albuquerque Business First.
Because cannabis takes longer than two months to be cultivated, the CCD was suspicious of the report.
After inspecting the company’s premises, the CCD alleged Golden Roots reported cultivation, transportation and sales in BioTrack but wasn’t able to provide officers who inspected the site evidence that the operator was cultivating cannabis.
In April, the CCD revoked Golden Roots’ license and issued a $10,000 fine, according to the news outlet.
The company requested a hearing, which the regulator scheduled for Sept. 1.
At the hearing, the CCD testified that the company’s dried-cannabis weights in BioTrack were suspicious because they didn’t seem to accurately reflect how much weight marijuana loses as it dries.
Company employees also poorly accounted for why they were making adjustments in the system of up to 24 pounds of cannabis, making comments such as “bad” or “mistake” in the software, Albuquerque Business First reported.
Golden Roots was fined $298,972.05 – the amount regulators allege the company made selling products that weren’t properly accounted for in BioTrack.
The CCD has been cracking down on cannabis operators accused of selling products procured from out-of-state or not grown legally:
- Regulators alleged in August that Albuquerque dispensary Sawmill Sweet Leaf sold out-of-state products and didn’t have a license for extraction.
- Paradise Exotics Distro lost its license in July after regulators alleged the company sold products made in California.
Golden Roots was the first alleged rulebreaker in New Mexico to be asked to pay a large fine.
Source: https://mjbizdaily.com/new-mexico-cannabis-operator-fined-loses-license-for-alleged-biotrack-fraud/
Four marijuana companies, including a multistate operator, have filed a lawsuit against U.S. Attorney General Merrick Garland in which they allege the federal MJ prohibition under the Controlled Substances Act is no longer constitutional.
According to the complaint, filed Thursday in U.S. District Court in Massachusetts, retailer Canna Provisions, Treevit delivery service CEO Gyasi Sellers, cultivator Wiseacre Farm and MSO Verano Holdings Corp. are all harmed by “the federal government’s unconstitutional ban on cultivating, manufacturing, distributing, or possessing intrastate marijuana.”
Verano is headquartered in Chicago but has operations in Massachusetts; the other three operators are based in Massachusetts.
The lawsuit seeks a ruling that the “Controlled Substances Act is unconstitutional as applied to the intrastate cultivation, manufacture, possession, and distribution of marijuana pursuant to state law.”
The companies want the case to go before the U.S. Supreme Court.
They hired prominent law firm Boies Schiller Flexner to represent them.
The New York-based firm’s principal is David Boies, whose former clients include Microsoft, former presidential candidate Al Gore and Elizabeth Holmes’ disgraced startup Theranos.
Similar challenges to the federal Controlled Substances Act (CSA) have failed.
One such challenge led to a landmark Supreme Court decision in 2005.
In Gonzalez vs. Raich, the highest court in the United States ruled in a 6-3 decision that the commerce clause of the U.S. Constitution gave Congress the power to outlaw marijuana federally, even though state laws allow the cultivation and sale of cannabis.
In the 18 years since that ruling, 23 states and the District of Columbia have legalized adult-use marijuana and the federal government has allowed a multibillion-dollar cannabis industry to thrive.
Since both Congress and the U.S. Department of Justice, currently headed by Garland, have declined to intervene in state-licensed marijuana markets, the key facts that led to the Supreme Court’s 2005 ruling “no longer apply,” Boies said in a statement Thursday.
“The Supreme Court has since made clear that the federal government lacks the authority to regulate purely intrastate commerce,” Boies said.
“Moreover, the facts on which those precedents are based are no longer true.”
Verano President Darren Weiss said in a statement the company is “prepared to bring this case all the way to the Supreme Court in order to align federal law with how Congress has acted for years.”
While the Biden administration’s push to reschedule marijuana would help solve marijuana operators’ federal tax woes, neither rescheduling nor modest Congressional reforms such as the SAFER Banking Act “solve the fundamental issue,” Weiss added.
“The application of the CSA to lawful state-run cannabis business is an unconstitutional overreach on state sovereignty that has led to decades of harm, failed businesses, lost jobs, and unsafe working conditions.”
Alabama regulators are targeting Dec. 1 to award the first batch of medical cannabis business licenses after the agency’s first two attempts were scrapped because of scoring errors and litigation.
The first licenses will be awarded to individual cultivators, delivery providers, processors, dispensaries and state testing labs, according to the Alabama Medical Cannabis Commission (AMCC).
Then, on Dec. 12, the AMCC will award licenses for vertically integrated operations, a designation set primarily for multistate operators.
Licenses are expected to be handed out 28 days after they have been awarded, so MMJ production could begin in early January, according to the Alabama Daily News.
That means MMJ products could be available for patients around early March, an AMCC spokesperson told the media outlet.
Regulators initially awarded 21 business licenses in June, only to void them after applicants alleged inconsistencies with how the applications were scored.
Then, in August, the state awarded 24 different licenses – 19 went to June recipients – only to reverse themselves again and scratch those licenses after spurned applicants filed lawsuits.
A state judge dismissed a lawsuit filed by Chicago-based MSO Verano Holdings Corp., but another lawsuit is pending.
Source: https://mjbizdaily.com/alabama-plans-to-award-medical-cannabis-licenses-dec-1/
New Mexico cannabis operator fined, loses license for alleged BioTrack fraud
Marijuana companies suing US attorney general in federal prohibition challenge
Alabama to make another attempt Dec. 1 to award medical cannabis licenses
Pot Odor Does Not Justify Probable Cause for Vehicle Searches, Minnesota Court Affirms
New Mexico cannabis operator fined, loses license for alleged BioTrack fraud
Alabama to make another attempt Dec. 1 to award medical cannabis licenses
-
Business1 year agoPot Odor Does Not Justify Probable Cause for Vehicle Searches, Minnesota Court Affirms
-
Business1 year agoNew Mexico cannabis operator fined, loses license for alleged BioTrack fraud
-
Business1 year agoAlabama to make another attempt Dec. 1 to award medical cannabis licenses
-
Business1 year agoWashington State Pays Out $9.4 Million in Refunds Relating to Drug Convictions
-
Business1 year agoMarijuana companies suing US attorney general in federal prohibition challenge
-
Business1 year agoLegal Marijuana Handed A Nothing Burger From NY State
-
Business1 year agoCan Cannabis Help Seasonal Depression
-
Blogs1 year agoCannabis Art Is Flourishing On Etsy